A version of this story first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
WASHINGTON — “Most* patients pay between $0 and $5 per month” for Janssen’s drug Stelara, the chart proclaims.
But, boy, does that asterisk contain quite the caveat. Way down at the other end of the graphic, any patient paying the list price is shelling out a whopping $11,002 every month for the same drug.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect